Epstein-Barr Virus-Encoded LMP2A Induces an Epithelial–Mesenchymal Transition and Increases the Number of Side Population Stem-like Cancer Cells in Nasopharyngeal Carcinoma by Kong, Qing-Li et al.
Epstein-Barr Virus-Encoded LMP2A Induces an Epithelial–
Mesenchymal Transition and Increases the Number of
Side Population Stem-like Cancer Cells in
Nasopharyngeal Carcinoma
Qing-Li Kong
1,2,3., Li-Juan Hu
1,2., Jing-Yan Cao
1,2., Yi-Jun Huang
4, Li-Hua Xu
1,2, Yi Liang
1,2, Dan
Xiong
1,2, Su Guan
1,2, Bao-Hong Guo
1,2, Hai-Qiang Mai
1,5, Qiu-Yan Chen
1,5, Xing Zhang
1, Man-Zhi Li
1,2,
Jian-Yong Shao
1, Chao-Nan Qian
1,5, Yun-Fei Xia
1,6, Li-Bing Song
1,2, Yi-Xin Zeng
1,2, Mu-Sheng Zeng
1,2*
1State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China, 2Department of Experimental Research,
Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China, 3Affiliated Hospital of Jining Medical College, Shandong, People’s Republic of China,
4Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, People’s Republic of China, 5Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University
Cancer Center, Guangzhou, People’s Republic of China, 6Department of Radiotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China
Abstract
It has been recently reported that a side population of cells in nasopharyngeal carcinoma (NPC) displayed characteristics of
stem-like cancer cells. However, the molecular mechanisms underlying the modulation of such stem-like cell populations in
NPC remain unclear. Epstein-Barr virus was the first identified human tumor virus to be associated with various
malignancies, most notably NPC. LMP2A, the Epstein-Barr virus encoded latent protein, has been reported to play roles in
oncogenic processes. We report by immunostaining in our current study that LMP2A is overexpressed in 57.6% of the
nasopharyngeal carcinoma tumors sampled and is mainly localized at the tumor invasive front. We found also in NPC cells
that the exogenous expression of LMP2A greatly increases their invasive/migratory ability, induces epithelial–mesenchymal
transition (EMT)-like cellular marker alterations, and stimulates stem cell side populations and the expression of stem cell
markers. In addition, LMP2A enhances the transforming ability of cancer cells in both colony formation and soft agar assays,
as well as the self-renewal ability of stem-like cancer cells in a spherical culture assay. Additionally, LMP2A increases the
number of cancer initiating cells in a xenograft tumor formation assay. More importantly, the endogenous expression of
LMP2A positively correlates with the expression of ABCG2 in NPC samples. Finally, we demonstrate that Akt inhibitor (V)
greatly decreases the size of the stem cell side populations in LMP2A-expressing cells. Taken together, our data indicate that
LMP2A induces EMT and stem-like cell self-renewal in NPC, suggesting a novel mechanism by which Epstein-Barr virus
induces the initiation, metastasis and recurrence of NPC.
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Introduction
Nasopharyngeal carcinoma (NPC) is the most frequent head
and neck tumor in Guangdong, South China, where the incidence
peaks at 50 per 100,000, but is rare in the Western world (1 per
100,000) [1,2]. NPC is a highly malignant cancer which often
invades adjacent regions and metastasizes to regional lymph nodes
and distant organs. Thirty to 60 percent of patients with NPC will
eventually develop a distant metastasis. Although NPC tumors are
sensitive to radiotherapy and chemotherapy, treatment failure is
high due to local recurrence and distant metastases, which are the
key contributors to NPC mortality [3]. However, the underlying
cellular and molecular mechanisms of NPC metastasis and
recurrence remain poorly understood.
The epithelial–mesenchymal transition (EMT) is characterized
as a switch from a polarized, epithelial phenotype to a highly
motile fibroblastoid or mesenchymal phenotype. EMT is critical to
metazoan embryogenesis, chronic inflammation and fibrosis, and
has been demonstrated to be a central mechanism in cancer
invasiveness and metastasis [4]. Recently, Weinberg and col-
leagues reported that EMT generates cells with stem cell-like
properties [5], which suggests that metastases are sometimes
caused by cancer cells that acquire stem cell characteristics.
Recent studies have also suggested that cancer stem cells (CSCs)
represent a small proportion of the cells in a tumor mass and
contribute to tumor initiation, metastasis and recurrence. It has
been further reported that cancer stem cells are enriched in side
population (SP) cells which can efflux the DNA binding dye,
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Wang and colleagues have reported that SP cells in the human
NPC cell line CNE2 display stem cell characteristics [9]. However,
the molecular mechanisms underlying the regulation of SP cells in
NPC remain unclear.
Epstein-Barr virus (EBV), which ubiquitously infects more than
90% of the world’s population, was the first human tumor virus
identified to be causally associated with various lymphoid and
epithelium malignancies [10]. However, the underlying mecha-
nism of how EBV contributes to cancer is still poorly understood.
NPC, particularly the undifferentiated type, is the most commonly
known EBV associated cancer [11] and three EBV latent proteins
are expressed in these tumors [12,13]. EBNA1, whose primary
role is to enable replication of the viral episomal genome [14], is
the most widely expressed protein in NPC. However, although
both LMP1 and LMP2A are detectable in NPC samples, much of
the recent research focus has been on LMP1 because of its known
oncogenic properties in B cells [15,16]. However, LMP2A has
been detected in more than 95% of NPC samples at the mRNA
level, and about 50% of these specimens at protein level, whereas
LMP1 could be detected in only about 65% or 35% of NPC
samples at mRNA or protein level, respectively [17,18,19,20,21].
In addition, the high LMP2A expression in NPC samples has been
reported to correlate with a poor survival outcome, although this
study was carried out using only a small cohort [22].
Functional studies indicate that LMP2A plays an important role
in the maintenance of EBV latent infection in B cells but is
dispensable for EBV-driven B-cell transformation [23]. In
epithelial cells, LMP2A has been reported to have transforming
properties i.e. to alter cell motility and inhibit cell differentiation
[22,24,25,26]. Activation of the PI3K/Akt, NF-kB, b-catenin,
STAT and Syk Tyrosine Kinase pathways has been suggested to
contribute to the various functions of LMP2A in epithelial cells
and B cells [26,27,28,29,30]. ITGa6 is thought to be involved in
the enhancement of cell migration mediated by LMP2A [22].
Most recently, LMP2A has been reported to induce promoter
hypermethylation of the pten gene in gastric carcinoma [31]. In
addition, some of the above functions and pathways modulated by
LMP2A have been reported to play roles in regulating the
proliferation and self-renewal properties of CSCs [32,33,34].
These findings thus raise the possibility that LMP2A may affect
oncogenic processes by modulating the CSC population in NPC.
We report in our current study that the stable expression of
LMP2A in NPC cells induces cell invasion and EMT-like
molecular alterations. More importantly, the overexpression of
LMP2A increases the size of the stem-like cell population and the
number of tumor initial cells. Our data thus represent the first
indication that LMP2A has an effect on stem cell-like populations
and provides additional clues to elucidating the role of LMP2A in
NPC progression.
Results
Characterization of novel LMP2A monoclonal antibodies
To detect LMP2A protein expression, monoclonal antibodies
(MoAbs) was raised against a glutathione-S-transferase-fused full-
length LMP2A protein (Proteintech Group Inc.). After primary
selection by ELISA, five clones were obtained from the
Proteintech Group and further characterized by western blotting
and immunofluorescence staining. To establish stably expressed
LMP2A cell lines, CNE2 and SUNE1 cells were infected with
virus expressing either LMP2A in the pBabe vector or with empty
vector alone, followed by selection in puromycin. No differences in
the efficiency of selection between vector and LMP2A-infected
cells were observed. RT-PCR analysis showed that LMP2A
mRNA was expressed in both of the LMP2A-infected cell lines
(Figure 1A). The expression of LMP2A protein was detectable by
immunoblotting with four different LMP2A MoAb clones.
Representative results for clone 4A11B3A3 are shown in
Figure 1A. In contrast to LMP2A-infected cells, there was no
detectable LMP2A mRNA or corresponding proteins in the vector
control cells. The membrane localization of LMP2A in the
LMP2A-infected NPC cells was confirmed by specific detection
with 4A11B3A3 using immunofluorescence staining (Figure 1B).
To further determine whether MoAb 4A11B3A3 could detect
LMP2A protein in archival NPC patient’s biopsies, we tested this
antibody in paraffin-embedded nude mice xenograft samples. In
accordance with our western blot results, by immunohistochem-
ical analysis we found strong membrane staining of LMP2A in
CNE2-LMP2A inoculated samples. No specific staining was
observed in CNE2-vector inoculated samples or in IgG detected
controls (Figure 1C). We then analyzed endogenous LMP2A
expression in NPC patient biopsies with the same MoAb by
immunohistochemical analysis and obtained similar results
(Figure 1D). Hence, the specificity and sensitivity of this antibody
for endogenous and exogenous LMP2A expression by immuno-
blotting, immunohistochemistry and immunofluorescence analy-
sis was verified.
Expression of LMP2A in the invasive front of cancer nests
in NPC biopsies
To further investigate the status of LMP2A expression in
NPC biopsies, immunohistochemical analyses were carried out
and revealed that 19 of 33 (57.6%) paraffin-embedded samples
showed moderate (Figure 1D, right panel) to strong (Figure 1D,
middle panel) staining of LMP2A in most of the tumor cells and
in some scattered infiltrated lymphocytes. No positive staining
w a sd e t e c t e di na d j a c e n tn o n c a n c e r o u se p i t h e l i a lc e l l s .A ss h o w n
in Figure 1B and E, LMP2A is mainly expressed on the tumor
cell membrane and preferentially located at the tumor invasive
front. We then tested six archival relapse patient samples and
found that were strongly positive for LMP2A expression. These
data suggest that LMP2A is expressed in NPC samples at
variable levels, that its localization at the invasive front is
indicative of a potential role in promoting tumor invasion, and
Author Summary
Epstein-Barr virus (EBV) infects about 90% of people
worldwide and persists benignly as a latent infection.
However, EBV is associated with different types of human
cancer. Nasopharyngeal carcinoma (NPC) is the most
commonly known EBV associated cancer and expresses a
well defined set of latent viral genes, including LMP2A,
which has been detected in the majority of NPC samples.
Several studies indicated this latent viral protein drove
cellular invasion and metastasis. For this study, enforced
LMP2A expressing NPC cell lines were generated. We show
here that LMP2A induces an Epithelial–Mesenchymal
Transition and increases the Stem-like Cancer Cells in
NPC. Our results suggest that LMP2A supports tumor
initiation and recurrence of the infected nasopharyngeal
epithelial cells. For the first time we report a virus protein
that functions in the initiation and progression of cancer
by inducing the cancer stem-like cells. These findings
permit a more detailed understanding of function and
contribution to viral pathogenesis and provide a novel
therapeutic target for NPC therapy.
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NPC recurrence.
The exogenous expression of LMP2A in NPC cells induces
EMT-like cellular marker alteration
It has been reported previously that LMP2A can promote the
migratory/invasive properties of different epithelial cell types [35].
As determined by immunostaining, dissected tumor tissue samples
from nude mice inoculated with CNE2-LMP2A cells showed a level
of LMP2A that was comparable to that found in the NPC biopsies
(Figure 1C and D). Hence, the established stable LMP2A
expressing NPC cell line was found to contain physiological levels
of LMP2A, and could thus be used in further studies of LMP2A
function. Consistent with previous reports, the expression of
LMP2A could enhance the migratory and invasive ability of
NPC cells (data not show). Since the enhanced migratory/invasive
ability of epithelial cells is often caused by EMT, we analyzed a
panel of representative epithelial and mesenchymal markers by
immunoblotting to determine whether this process occurs in
LMP2A-expressing NPC cells. The results showed that the
overexpression of LMP2A caused an EMT-like marker shift in
the cells, including a dramatic downregulation of the epithelial
markers E-cadherin and a-catenin, and upregulation of the
mesenchymal markers fibronectin and the EMT-associated tran-
scription factor snail, although the change of vimentin was
moderate with about 2-fold increase in CNE2-LMP2A cells as
analyzed by Quantity One software (Figure 2A). Immunofluores-
cence staining further revealed that the expression of E-cadherin
and a-catenin, which shows membrane localization in control cells,
Figure 1. Endogenous and exogenous expression of LMP2A detected using monoclonal antibodies. A. Stable expression of LMP2A in
NPC cells. The left and right panels reveal the stable ectogenic expression of LMP2A in both CNE2 and SUNE1 NPC cell lines. The upper and lower
panels show mRNA and protein levels, respectively. B. Immunofluorescence staining clearly showing the membrane localization of LMP2A in the
CNE2 and SUNE1 cell lines. C. Immunohistochemical analysis of LMP2A expression in a nude mice xenograft of LMP2A-expressing CNE2 cells using
MoAb 4A11B3A3 or control IgG. D. Immunohistochemical analysis of endogenous LMP2A expression in NPC biopsies using MoAb 4A11B3A3 or
control IgG. Representative moderate (left panel) and strong (middle panel) staining results are shown. E. Immunohistochemical analysis (left panel)
with the MoAb 4A11B3A3 shows specific staining of LMP2A in NPC tumor nests (indicated by black arrows) but not in adjacent normal tissues
(indicated by red arrow). The middle and right panels show that LMP2A is usually expressed in the invasive tumor front cells and is mainly localized
on the cell membrane.
doi:10.1371/journal.ppat.1000940.g001
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upper two panels). In contrast, the levels of fibronectin, vimentin
and snail were strongly induced in LMP2A-expressing cells
(Figure 2B, lower three panels). These results thus demonstrate
that LMP2A induces EMT-like molecular alterations in NPC cells.
However, similar to a previously reported observation in squamous
epithelial cells [35], LMP2A did not induce any obvious
morphological changes in NPC cells in monolayer cultures.
Figure 2. The overexpression of LMP2A in NPC cell lines induces EMT-like cellular marker alterations. A. Western blotting of E-cadherin,
a-catenin, vimentin, fibronectin and snail in the vector control and LMP2A-expressing cells. B. Immunofluorescence staining reveals a reduced
expression of E-cadherin, a-catenin and an increased expression of vimentin, fibronectin and snail in LMP2A-expressing cells in comparison with the
vector controls.
doi:10.1371/journal.ppat.1000940.g002
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the representative EMT markers after transient tranfection of
LMP2A in NPC cells. As shown in Figure S1, EMT-like molecular
alterations were induced by transient expression of LMP2A in
both CNE2 and SUNE1 cells. To further investigate whether
endogenous LMP2A contributes to the EMT phenomenon, we
tested whether NPC cells lacking this endogenous expression
demonstrated any EMT-like cellular marker reversal as compared
with LMP2A-expressing cells. Following the knockdown of
LMP2A in C666 cells (Figure S2A), we found by immunofluores-
cence staining that the expression of the epithelial marker E-
cadherin was up-regulated, whereas the mesenchymal marker
vimentin was down-regulated on the membranes of the cells
(Figure S2B). These results indicate that LMP2A is necessary for
the EMT-like marker shift in NPC cells.
LMP2A up-regulates stem cell marker expression and
increases the stem cell-like population in NPC
It has been reported recently that EMT generates cells showing
the properties of stem cells [5]. We thus determined whether stable
expression of LMP2A could induce such stem cell-like phenotypes
in NPC. Representative stem cell markers were thus analyzed by
RT-PCR or western blot. As shown in Figure 3A (left panel), in
comparison with the vector control, LMP2A expression up-
regulates the stem cell markers ABCG2, Bmi-1, Nanog, and
SOX2 at the transcriptional level. The increases in ABCG2, Bmi-
1, SOX2 and Nanog were further confirmed at the protein level
(Figure 3A, right panel). As expected, transient expression of
LMP2A could also induce stem cell markers, as demonstrated by
the increased expression of ABCG2 and Bmi-1 at both
transcriptional and protein levels (Figure S3A).
Side populations (SPs) among NPC cells have been reported to
exhibit cancer stem cell characteristics [9]. We wished therefore to
determine whether the increased expression of stem cell markers
we observed in LMP2A-expressing cells was caused by an increase
in the size of the stem cell-like SPs. As shown in Figure 3B, the
stable expression of LMP2A dramatically increases the size of the
SP in the CNE2 (from 1.04% to 8.32%) and SUNE1 (from 3.38%
to 13.72%) cell lines. Importantly, SPs were also increased in
transient LMP2A expressing cells CNE2 (from 1.56% to 3.65%)
and SUNE1 (from 3.91% to 11.37%) (Figure S3B). Interestingly
however, we did not observe any SPs in either wild type or
LMP2A knockdown C666 cells.
Previously, we have reported that the side population (SP) cells,
isolated from CNE2 NPC cell line, exhibited cancer stem cell
characteristics [36]. Thus, we sorted the SP fraction in CNE2-
Vector, CNE2-LMP2A, SUNE1-Vector and SUNE1-LMP2A
cells, respectively, and then performed colony formation assay.
As shown in Figure S4, SP fraction from either LMP2A or vector
control cells form larger and more colonies compared with the
non-SP fraction, confirmed that the stem cell population is indeed
within the SP fraction in NPC cell lines. Taken together, our
results demonstrate that LMP2A could induce expression of stem
cell markers and increase the stem cell population in NPC cells.
LMP2A induces stem cell-like self-renewal properties
We next analyzed whether the increase in the sizes of the SPs in
NPC is due to the enhanced self-renewal properties of the stem-
like cells therein. LMP2A and control cells were cultured in
suspension to generate spheres, the number and sizes of which
reflect both the quantity and ability of cells to self-renew in vitro
[36]. As shown in Figure 3C, LMP2A-expressing cells formed
more and larger spheres than vector controls cells did in both NPC
cell lines (CNE2, P=0.04; SUNE1, P=0.03). We conclude from
this that LMP2A can indeed enhance stem cell self-renewal
properties, and thereby increase the size of these populations.
LMP2A enhances the transforming ability of NPC cells
To investigate whether LMP2A can enhance the transforming
ability of NPC cells, we used both a colony formation and
anchorage-independent growth assay in soft agar. We plated 200
NPC cells in triplicate wells of six-well plates for the colony
formation assay. After 14 days of culture, LMP2A-expressing cells
formed colonies that were significantly larger than those of the
vector control cells (Figure 4A). There were also more LMP2A-
expressing than vector control colonies. Statistical analysis showed
significant differences in the number of colonies between the
LMP2A-expressing and vector control cell lines (P,0.05; Figure 4A,
right panel). In addition, the transforming ability of LMP2A
expressing cells was also determined by soft agar assay. As shown in
Figure 4B, LMP2A-expressing cells formed significantly more and
larger colonies compared to the vector cells in soft agar assay.
LMP2A increases the number of tumor initiating cells in
vivo
As SPs are enriched for tumor initiating cells, we next assessed
the effects of LMP2A upon the tumorigenicity of NPC cell lines in
nude mice. As shown in Figure 5, when injected with 1610
6 cells,
the palpable tumors formed by LMP2A cells and control cells
appeared at a similar time and grew at a comparable rate. As the
injected cell number was reduced however (cell numbers at 1610
5,
1610
4 or 1610
3), the growth rates of the LMP2A tumors were
found to be higher than those of controls injected with the same
cell numbers. The data in Figure 5B show that when injected with
1610
5,1 610
4 or 1610
3 LMP2A-expressing NPC cells, 96% of
the nude mice (27/28) developed tumors, whereas only 61% of
these mice (17/28) did so when injected with the control cells.
When 1610
3 cells were injected, the control cells formed only
small tumors in 5/10 mice after 20 days whereas LMP2A-
expressing cells formed tumors in 10/10 mice. In addition, the first
palpable tumor in the LMP2A groups injected with 1610
3 cells
appeared within 13 days, six days earlier than the control. Mice
were sacrificed at 14, 17 or 20 days after injection, and the tumors
were then weighed and photographed (Figure S5A and B). In all
cases, the sizes of the tumors formed by the LMP2A-expressing
NPC cells were larger than the vector control cells except in the
1610
6 cell inoculation groups. This difference was most apparent
in the 1610
3 cell group (P=0.004). Hence, LMP2A increases the
number of tumor initiating cells in NPC.
LMP2A expression correlates with EMT-like and stem cell
markers’ expression in NPC samples
To determine whether any correlation existed between LMP2A
expression and the representative markers of EMT and stem cell
in NPC biopsy samples, we obtained RNA from 15 inflammatory
samples and 18 NPC samples and analyzed LMP2A, ABCG2,
Bmi-1, E-cadherin (E-cad) and Fibronectin (FN1) expression using
real-time RT-PCR. LMP2A, Bmi-1 and ABCG2 transcripts were
found to be low or undetectable in the 15 inflammatory samples
but extremely high in the NPC tumor tissue (Figure 6A). We also
found that LMP2A expression positively correlates with ABCG2,
Bmi-1 and Fibronectin, and negatively correlates with E-cadherin
(Figure 6B).
In addition, we also detected LMP2A, Bmi-1, E-cadherin
proteins in another 42 NPC biopsies. As shown in Figure 6C and
Figure 6D, LMP2A correlated positively with Bmi-1, and
negatively with E-cadherin.
LMP2A Induces EMT and Side Population Cells in NPC
PLoS Pathogens | www.plospathogens.org 5 June 2010 | Volume 6 | Issue 6 | e1000940Akt activity contributes to the up-regulation of SP cells
by LMP2A
As previously shown, the expression of LMP2A in B
lymphocytes and HaCaT cells induces the activation of Akt in a
PI3K-dependent manner [26,28]. To investigate the Akt status in
NPC cells in our current study, western blot analysis using an
antibody that detects Thr308 phosphorylation of Akt was
performed to detect activated Akt (Figure 7A). Phospho-Akt
(Thr308) was found to be up-regulated at least 2.5 folds in
LMP2A-expressing cells compared with control cells as analyzed
by Quantity One. Phospho-GSK3b, a direct target of Akt GSK3b
[37], was further found to be induced in LMP2A cells (Figure 7A).
After treatment with Akt inhibitor (V) at 4 mM for 12hours, the
phosphorylation of Akt was suppressed in both the LMP2A and
vector control NPC cells (Figure 7B). It is noteworthy, however,
that the SPs were dramatically reduced in NPC cell lines in the
presence of Akt inhibitor (V), particularly in LMP2A-expressing
cells. As shown in Figure 7C, the size of the SP decreased from
Figure 3. LMP2A induces stem-like properties in NPC cells. A. The right and left panels show up-regulated expression of the stem cell markers
ABCG2, Bmi1, Nanog, SOX2 at both the mRNA and protein levels, respectively. B. LMP2A increases the size of the side population (SP) cells. Flow
cytometric profiles of SP cells among the CNE2 and SUNE1 NPC cell lines after stable expression of LMP2A. SP cell profiles in the presence of
verapamil are shown in the bottom panels. The percentages of SP cells are indicated. C. LMP2A induces stem cell-like self-renewal properties. Sphere
sizes are shown in the left panels, and the numbers of spheres in both LMP2A-positive and -negative cells are shown in the right panels.
doi:10.1371/journal.ppat.1000940.g003
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SUNE1-LMP2A cells. Thus, the Akt pathway seems to play a role
in the LMP2A-mediated increase of NPC SP cells, although this
will need to be further confirmed using dominant negative mutants
or shRNAs that target Akt in LMP2A-expressing cells.
Most importantly, these results were further confirmed by
transient expression of LMP2A. Figure S6A, phospho-Akt
(Thr308) and phospho-GSK3b were upregulated in LMP2A
positive cells consistent with the above results. And after treatment
with Akt inhibitor (V), we observed the similar results (Figure S6B).
Moreover, as shown in Figure S6C, the size of the SP decreased
from 13% to 7.06% in transient CNE2-LMP2A cells.
Discussion
The results of our current study indicate a pivotal role for
LMP2A in the progression of NPC via stem-like cancer cell
induction. The novel functions of LMP2A in inducing EMT,
increasing the size of the SP, enhancing the self-renewal properties
of stem-like cancer cells, and increasing the number of cancer
initiating cells, confirm the involvement of this protein in
oncogenic processes through the modulation of the CSC
population in NPC.
Many studies have recently focused on the function of LMP2A
in B cells. Although LMP2A is not required for EBV transforma-
tion of human B cells [38,39,40], it can drive B-cell development
and survival by mimicking B-cell receptor (BCR) signal transduc-
tion [23,41,42,43,44]. The profiling of genes that are involved in
different biological signaling pathways in EBV-associated cancers,
in comparison with those of LMP2A transgenic mice, indicates
that LMP2A may play a key role in tumorigenesis [45,46]. As
reported, LMP2A can be detected in approximately half of
Hodgkin’s lymphomas [47], and routinely detectable in nasopha-
Figure 4. LMP2A enhances the transforming ability of NPC cells. A. Colony formation assay of the CNE2 and SUNE1 cell lines. Upon the stable
expression of LMP2A, these cells form bigger (left panel) and more colonies (right panel) compared with the vector control cells. Error bar=SD. B. The
anchorage-independent growth in soft agar of CNE2 and SUNE1 cells with or without exogenous LMP2A expression. Error bar=SD; scale bar=200 mm.
doi:10.1371/journal.ppat.1000940.g004
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important roles in the induction of human cancers of EBV.
Previous studies suggesting that LMP2A may be involved in cell
proliferation have come from the Raab-Traub and Tsai
laboratories, which have independently demonstrated that
LMP2A has dramatic effects on epithelial cells, such as the ability
Figure 5. LMP2A enhances the initial tumor cell population in CNE2 cells. A. Tumor growth curves after injection of nude mice with LMP2A
or vector control expressing NPC CNE2 cells. Once they become palpable, the LMP2A tumor (red) cells grow at a higher rate than the vector control
(blue) cells in all cases. This difference becomes more pronounced when the injected cell number is 10
4 and 10
3. B. Tumors become palpable at an
earlier timepoint and grow at a faster rate in LMP2A-expressing cells compared with vector control cells. Tumor formation was monitored for 20 days
after injection of nude mice. Differences were not evident when the injected cell number was above 10
5. However, at 10
3 and 10
4 cells, the
differences were significant. In the case of injections with 10
4 cells followed by monitoring for 17 days, 9 tumors arose in 10 mice for LMP2A-
expressing cells, whereas only 6 of 10 mice infected with vector control cells formed tumors. When 10
3 cells were injected followed by monitoring for
20 days, all mice formed tumors in the LMP2A-expressing cell group, but only half of the mice did so in the vector control group.
doi:10.1371/journal.ppat.1000940.g005
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growth in nude mice, inhibit epithelial cell differentiation, and
activate cell motility [24,26].
Consistent with previous findings [20,21,22], we observed
LMP2A protein in 57.6% of the NPC specimens analyzed in
our present study. More importantly, we found that LMP2A
localized predominantly at the tumor invasive front, indicating its
role in promoting tumor invasion and migration. Indeed, invasion
and metastasis are major features of NPC. Many types of cancer
cells derived from primary carcinoma appear to rely on the EMT
program to facilitate most of the steps in the invasion-metastasis
cascade, in which the down-regulation of E-cadherin is a key initial
event [48]. However, the last step in this process, which is termed
colonization, requires that the cells that migrate from the original
tumor site possess the self-renewal capability to form the
macroscopic metastases in addition to an EMT ability [5]. The
significance of our present results is underscored by the fact we
have demonstrated for the first time that the EBV latent
membrane protein LMP2A can confer stem-like properties upon
NPC cells whilst at the same time promote EMT. Our findings are
in agreement with and support the previous observation of a direct
link between EMT and the gain of epithelial stem cell properties
[49], to our knowledge the first report of a connection of this
nature. It will be important to perform a study in a larger cohort of
Figure 6. The expression of LMP2A correlates with the expression of EMT and stem cell-related markers in NPC. A. The mRNA level of
LMP2A, ABCG2, Bmi-1, E-cadherin and Fibronectin in NPC biopsy samples and control inflammatory samples measured by real time RT-PCR.
T=tumor, N=normal. B. LMP2A correlates positively with ABCG2, Bmi-1, Fibronectin, and negatively with E-cadherin in tissue samples. T=tumor,
N=normal. C. The expression of LMP2A, Bmi-1 and E-cadherin in a cohort of NPC biopsy using immunohistochemistry assay. Final magnification 40X,
scale bar=50 mm. D. LMP2A significantly correlates with Bmi-1and E-cadherin in NPC tissues. The coordinate axis equals to the percentage of positive
cells in whole cancer cells.
doi:10.1371/journal.ppat.1000940.g006
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between LMP2A and ABCG2 expression and the clinicopatho-
logical characteristics of NPC.
Acquisition of the EMT phenotype in epithelial tumor cells is
believed to play critical roles in the increased invasiveness and
metastatic potential of tumor cells, and this process is causative for
the development of ‘‘cancer stem-like cell’’ characteristics. The
evidence thus far suggests that tumors arise from a diseased stem
cell derived from a progenitor cell population and that many
cancers, not unlike normal organs, contain a small population of
cells with a high proliferative capacity, self-renewing potential,
multi-differentiation ability, and that are resistant to chemother-
apy and radiotherapy. All of these properties are characteristic of
normal adult stem cells and even embryonic stem cells. Thus, this
subpopulation of cells is denoted CSCs or tumor stem cells
[50,51,52].
Our current study demonstrates that the LMP2A induces a stem
cell state, evidenced by an enhanced self-renewal and transfor-
mational capacity, and also increases the number of tumor
initiating cells in vivo. This was further confirmed by the greatly
increased SP size and higher expression at both the transcriptional
and translational level of some stem cell markers, such as ABCG2,
Nanog, Bmi-1 and SOX2. Compared with most non-tumorigenic
cancer cells, SP cells have a strong ability to form tumors after
transplantation. Because SP cells are also resistant to chemother-
apy and radiotherapy, they may contribute to tumor relapse even
Figure 7. Akt contributes to the enhancement of the SP by LMP2A. A. Phospho-Akt (Thr308) and phospho-GSK3b were analyzed by Western
blotting. B. The suppression of phospho-Akt (Thr308) in LMP2A-expressing and vector control cells after Akt inhibitor treatment determined by
western blot analysis. C. The reduction in the SP after Akt inhibitor treatment detected by flow cytometry.
doi:10.1371/journal.ppat.1000940.g007
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indeed show that the transcription factors OCT4, SOX2, and
Nanog have essential roles in early development and are required
for the propagation of undifferentiated embryonic stem (ES) cells
in culture [54,55,56,57]. More importantly, the positive correla-
tion of LMP2A and ABCG2 expression in NPC specimens
provides a valuable clue to further elucidating the processes
underlying clinical metastasis and recurrence in NPC.
It is tempting to speculate regarding the actual mechanisms by
which LMP2A induces EMT and cancer stem-like characteristics.
Previous studies showed that Syk inhibition could impair LMP2A-
mediated cell migration; and the mutation of Tyr-74 and Tyr-85,
the LMP2A ITAM, simultaneously blocked Syk activation and cell
migration [30]. It also has been previously shown that the
constitutive activation of the Ras/PI3-K/Akt pathway by LMP2A
is a key element of LMP2A-mediated transformation, whereas the
cell adhesion signaling and MAPK pathways are not activated in
LMP2A tumors [25,26]. Our current data also show that LMP2A
activates Akt in NPC cells and that after treatment with Akt
inhibitor (V) for 12 hours, the SP cell population decreased greatly
in LMP2A-expressing cells. It is well known that NF-kB plays an
important role in mediating the processes of EMT induced by
different factors through the upregulation of the transcriptional
repressor functions of ZEB1 and ZEB2, the zinc-finger E-box
binding homeobox proteins essential in E-cadherin regulation
[58,59]. Moreover, the PI3-K/Akt/mTOR pathway could
indirectly activate NF-kB activity by regulating glycogen synthase
kinase (GSK)-3b phosphorylation [60]. The importance of PI3K/
Akt signaling in the proliferation and maintenance of embryonic
stem cell (ESC) self-renewal has previously been suggested [33,34],
and its involvement in the regulation of the representative
pluripotency marker genes, Oct4, Sox2, and FoxD3, has also been
reported in a recent study [61]. Further more, LMP2A induces
expression of polycomb group protein Bmi-1, which has been
recently reported to play an important role in progression of NPC
by inducing EMT and maintenance of stem-like phenotype via
PTEN/Akt/Snail signaling [62]. Taken together, these results
suggest that the PI3K/Akt pathway, at least in part, contributes to
the EMT process and also the SP stem-like cancer cell shift of
NPC epithelial cells. However, the underlying mechanisms how
LMP2A modulates the Akt activity and expression of Bmi-1 in
NPC cells requires further investigation. Importantly, some effects
induced by LMP2A on EMT are also induced by LMP1 [63]. It
will be interesting to determine whether LMP1 and LMP2A
collaborate in inducing EMT and stemness of NPC cells.
It must be noted that the lack of effective SP sorting of
endogenous LMP2A knockdown cells limits our ability to
determine whether LMP2A alone is sufficient to increase the size
of the SP. In addition, the complex regulatory machineries
associated with LMP2A during cancer stem cell induction have
not been fully elucidated. Hence, elucidation of the underlying
signaling network that regulates the LMP2A pathways by using
various LMP2A mutants and different pathway inhibitors will
provide important further insights into the exact role of this viral
protein in the emergence of cancer stem cells.
Conclusions
We show for the first time herein that the EBV latent membrane
protein LMP2A can induce EMT and increase the number of
tumor initiating cells. Our data first indicated that LMP2A
strongly up-regulates the cancer stem cell-like population in NPC,
which may explain the onset of metastases and high rate of
recurrence for these tumors. This raises the possibility that this
viral protein plays a key role not only in EBV latency and
persistence but also in the progression of NPC. Based on our novel
findings, we believe that the pathologic diagnosis together with
detection of LMP2A in tumor tissue will aid in predicting NPC
progression, and that LMP2A can be considered to be a novel
therapeutic target for this cancer.
Materials and Methods
Ethics statement
All animal work was conducted under the institutional
guidelines of Guangdong Province and approved by the Use
Committee for Animal Care. Approval from the Sun Yat-sen
University Institute Research Ethics Committee was obtained, and
written informed consent was provided by each human subject.
Establishment of LMP2A stable expressing and
knockdown cell lines
Two poorly differentiated nasopharyngeal carcinoma cell lines
(CNE2, SUNE1) were maintained in RPMI 1640 medium (Life
Technologies, Carlsbad, CA) supplemented with 10% fetal bovine
serum (FBS) in a humidified 5% CO2 incubator at 37uC. To
generate stable cell lines, recombinant retroviruses expressing
either vector pBabe or pBabe subcloned with LMP2A were
generated as previously described [64] and used to infect CNE2
and SUNE1 cells [65]. Pooled CNE2 and SUNE1 cell populations
expressing either pBabe or pBabe-LMP2A were selected with 0.5
mg/mL of puromycin (Sigma-Aldrich, St Louis, MO).
C666, the only well-known nasopharyngeal carcinoma cell line
consistently carrying EBV, was chosen to perform the stable
knockdown of LMP2A expression. Retroviral particles were
generated and used to infect the target C666 cells as described
previously [66]. The successful knockdown of LMP2A was verified
by RT-PCR and immunofluorescence.
Antibodies
An LMP2A monoclonal antibody was obtained from Protein-
tech Group Inc. ABCG2 (Cat. 3380) and Nanog (Cat. 21603)
antibodies were obtained from Abcam (Cambridge, UK).
Antibodies raised against E-cadherin (Cat. 610181), a-catenin
(Cat. 610193), fibronectin (Cat. 610077), and vimentin (Cat.
550513) were purchased from BD Biosciences (Franklin Lakes,
NJ). Mouse anti-Bmi-1 (Upstate Biotechnology, Lake Placid, NY),
and rabbit-anti-GSK-3b, p-GSK-3b, Akt (Cell Signaling, Beverly,
MA) and p-Akt (Santa Cruz Biotechnology, CA.) primary
antibodies, and FITC or rhodamine-conjugated goat anti-rabbit
IgG or goat anti-mouse IgG (Jackson Laboratory, West Grove,
PA) or Peroxidase-conjugated goat anti-rabbit IgG or goat anti-
mouse IgG (Amersham Pharmacia Biotech, Piscataway, NJ)
secondary antibodies were used for western blot or immunoflu-
orescence analysis.
Tissue samples
Freshly frozen biopsied tissues from a total of 18 NPC patients
and 15 normal controls, and 81 paraffin-embedded NPC samples
which had been histologically and clinically diagnosed were
collected from the archives of the Department of Sample
Resources, Cancer Center, Sun Yat-sen University (Guangzhou,
China). Prior informed consent from the patients and approval
from the Institute Research Ethics Committee was obtained.
Sorting of SP cells by flow cytometry
Cells were analyzed by FACS when the cells had reached a
logarithmic growth phase (24 hours after replating). Cells were
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washed twice with calcium/magnesium-free PBS, resuspended in
ice-cold RPMI 1640 culture (supplemented with 2% FBS) at a
concentration of 1610
6 cells/mL, and incubated at 37uCi na5 %
CO2 incubator for 10 min. The DNA binding dye, Hoechst 33342
(Sigma-Aldrich, St. Louis, MO), was then added at a final
concentration of 5 mg/mL and the samples were incubated for
90 min in the dark with periodic mixing. The cells were then
washed twice with PBS, 1 mg/mL propidium iodide (Sigma-
Aldrich) was added, and the cells were kept at 4uC in dark prior to
sorting by a Moflo XDP (Beckman Coulter, Fullerton, CA).
Because Hoechst 33342 extrudes from cells treated with verapamil
(a calcium ion tunnel antagonist)-sensitive ABC transporters, a
subset of the cells were incubated with 50 mmol/L verapamil for
30 min at 37uC before the addition of Hoechst 33342 to
determine whether this would block the fluorescent efflux of SP
cells in the CNE2 and SUNE1 populations.
RT-PCR
Total RNA extracts from LMP2A-overexpressing cells and
pBabe vector control cells were prepared using a Trizol reagent
(Life Technologies, Grand Island, NY) according to the manufac-
turer’s instructions. The RNA was then treated with DNase, and
2.5 mg aliquots were used for cDNA synthesis using random
hexamers. The primers used for the amplification of the indicated
genes are listed in Table S1.
Real time RT-PCR
The expression levels of LMP2A, ABCG2, BMI-1, E-cadherin
and Fibronectin mRNA was determined by SYBR green real-time
reverse transcription-PCR (RT-PCR). Total RNA from different
human nasopharyngeal tissues were extracted using Trizol reagent
(Invitrogen, Carlsbad, CA). Quantitative dertermination of RNA
levels were performed in triplicate in three independent experi-
ments. Real-time PCR and data collection were performed with
an ABI PRISM 7900HT sequence detection system. The
housekeeping gene GAPDH was used as an internal control to
normalize the expression levels of different genes. The primers
used for the amplification of the indicated genes are listed in Table
S2.
Western blotting
Western blotting analysis was performed as previously described
[67]. Where relevant, the blots were probed with antibodies as
labeled in the figures, and the signals were detected using
enhanced chemiluminescence (ECL) (Amersham Pharmacia
Biotech, Piscataway, NJ). The membranes were stripped and
probed with an anti-alpha tubulin mouse monoclonal antibody
(Santa Cruz Biotechnology, Santa Cruz, CA) to confirm equal
loading of the samples.
Immunofluorescence analysis
Immunofluorescence analysis was performed as described
previously [67]. Cell lines were plated on culture slides (Costar,
Cambridge, MA) and after 24 hours were rinsed with phosphate-
buffered saline (PBS) and fixed in ice-cold methanol-acetone for
5 min at -20uC. The cells were then blocked for 30 min in 10%
BSA (Sigma-Aldrich St. Louis, MO) in PBS and then incubated
with primary monoclonal antibodies in PBS for 2 hours at room
temperature. After three washes in PBS, the slides were incubated
for 1 h in the dark with secondary goat anti-mouse, or goat anti-
rabbit antibodies (Invitrogen, Carlsbad, CA). After three further
washes, the slides were stained with 4-,6-diamidino-2-phenylindole
(DAPI; Sigma-Aldrich St. Louis, MO) for 5 min to visualize the
nuclei, and examined using an Olympus confocal imaging system
(Olympus FV100).
Anchorage-independent growth assay
Six-well plates were coated with a layer of 0.6% agar in medium
supplemented with 20% fetal bovine serum. Cells were prepared
in 0.3% agar and seeded in triplicate. The plates were then
incubated at 37uC in a humid atmosphere of 5% CO2 for two
weeks until colonies had formed. Each experiment was repeated at
least three times. Colonies were photographed between 18–24
days (final magnification 20 X) under a phase contrast microscope,
and colonies larger than 50 mm in diameter were counted under a
light microscope.
Colony formation assay
Cells were counted, plated in triplicate at 200 cells for the
pooled population or 100 sorted cells per well in six-well plates,
and cultured with RPMI 1640 complete culture for 10 days. After
most of the colonies had expanded to more than 50 cells, they
were washed twice with PBS, fixed in methanol for 15 min, and
dyed with crystal violet for 15 min at room temperature. After
washing out the dye, the plates were photographed. To quantify
the colonies objectively, the software Quantity One was used and
colonies that lager than the averaging parameter of 3 or 1 and the
minimum signal intensity of 1.0 were counted. At least three
independent experiments were carried out for each assay.
Tumor formation in an animal model
Nude mice were purchased from the Shanghai Slac Laboratory
Animal Co. Ltd and maintained in microisolator cages. All
animals were used in accordance with institutional guidelines and
the current experiments were approved by the Use Committee for
Animal Care. Tumor cells were suspended in 200 ml RPMI 1640
complete culture with 25% Matrigel (BD Biosciences) and
inoculated subcutaneously into the left flanks of 4- to 5-week-old
nude mice. The mice were monitored daily for palpable tumor
formation and tumors were measured using a Vernier caliper, and
also weighed and photographed.
Accession numbers
The Entrez Gene ID for genes and proteins mentioned in the
text are 3783751 (LMP2A), 2597 (GAPDH), 10376 (a-Tubulin),
999 (E-cadherin), 2335 (Fibronectin), 7431(Vimentin), 1495 (a-
Catenin), 9429 (ABCG2), 648 (Bmi-1), 79923 (Nanog), 6657
(SOX2), NG_012188 (Akt), NG_012922 (GSK-3b).
Supporting Information
Table S1 Primers for RT-PCR
Found at: doi:10.1371/journal.ppat.1000940.s001 (0.03 MB
DOC)
Table S2 Primers for real-time RT-PCR
Found at: doi:10.1371/journal.ppat.1000940.s002 (0.03 MB
DOC)
Figure S1 Transient expression of LMP2A induces EMT
molecular alterations. 5610
5 CNE2 or SUNE1 cells were seeded
per 100-mm dish and transfected next day with 8 mg of pCR3.1-
LMP2A or control vector together with 1mg of EGFP-expressing
vector using the FuGENE 6 reagent. EGFP positive cells were
sorted out from the co-transfected cells 48h later, and then were
used for western blot (A) or immunostaining analysis (B) to detect
the EMT related markers as indicated. The expression of LMP2A
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orescence staining (B, upper panel).
Found at: doi:10.1371/journal.ppat.1000940.s003 (3.43 MB TIF)
Figure S2 The suppression of endogenous LMP2A reverses the
EMT-like cellular marker shift. A. Stable knockdown of
endogenous LMP2A in EBV-positive NPC (C666) cells verified
by immunofluorescence staining (left panel) and RT-PCR (right
panel). B. The expression of E-cadherin and vimentin in LMP2A-
shRNA and control C666 cells analyzed by immunofluorescence
staining.
Found at: doi:10.1371/journal.ppat.1000940.s004 (4.81 MB TIF)
Figure S3 LMP2A up-regulates stem cell marker expression (A)
and increases the stem cell-like population (B) in transiently
transfected NPC cell lines. A. Cells were transfected and sorted as
described in Figure S1. The sorted cells were used for detection the
representative stem cell markers ABCG2 and Bmi-1 at both the
mRNA (left panel) and protein levels (right panel). B. 5610
5
CNE2 or SUNE1 cells were seeded per 100mm dish and
transfected next day with 8 mg of pCR3.1-LMP2A or control
vector. The transfected cells were replated 24h later, and were
cultured for another 24h before SP fraction analysis. SP cell
profiles in the presence of verapamil are shown in the bottom
panels. The percentages of SP cells are indicated.
Found at: doi:10.1371/journal.ppat.1000940.s005 (0.65 MB TIF)
Figure S4 SP fraction cells present high colony formation
ability. Colony formation assay of the non-SP fraction and SP
fraction from CNE2 vector cells (A), CNE2-LMP2A cells (B),
SUNE1 vector cells (C), SUNE1-LMP2A cells (D). The SP
fraction from either LMP2A or vector control cells form larger (left
panel) and more colonies (right panel) compared with the non-SP
fraction. 100 sorted SP or non-SP fraction cells were seeded per
well in six-well plates and cultured for 10 days. The representative
results of three independent experiments were presented as
indicated. Error bar=SD.
Found at: doi:10.1371/journal.ppat.1000940.s006 (5.68 MB TIF)
Figure S5 LMP2A increases the tumor initiating cell number in
CNE2 cells in vivo. A. NPC CNE2 tumors were weighed and
photographed after dissection from nude mouse xenografts. In all
cases, the tumors formed by LMP2A-expressing cells were larger
than the controls. This difference was most pronounced for
injections with 10
3 cells. B. Statistical analysis of NPC CNE2
tumor formation. Following injection with 10
5 and 10
6 cells, no
significant differences were evident. At 10
4 cells however, the
tumors formed by LMP2A-expressing cells were much larger than
those derived from vector control cell injections although this was
not statistically significant. Following 10
3 cell injections however,
the differences were statistically significant (P,0.01).
Found at: doi:10.1371/journal.ppat.1000940.s007 (3.26 MB TIF)
Figure S6 Akt activity contributes to the up-regulation of SP
cells in transiently tranfected LMP2A cells. A, B. Cells were co-
transfected and sorted as described in Figure S1. The sorted GFP
positive cells were either used to analyze the phospho-Akt
(Thr308) and phospho-GSK3b by western blotting (A), or replated
and harvested for analysis of phospho-Akt (Thr308) after after Akt
inhibitor treatment (B). C. Cells were transfected and processed in
a similar way as described in Figure S2B, in addition treated by
Akt inhibitor treatment for 8h before SP analysis.
Found at: doi:10.1371/journal.ppat.1000940.s008 (0.93 MB TIF)
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